BioCentury
ARTICLE | Company News

Elixir Medical sales and marketing update

January 20, 2014 8:00 AM UTC

Elixir launched its DESolve Novolimus Eluting Bioresorbable Coronary Scaffold System in Europe to treat coronary artery disease (CAD). The scaffold is available in diameters of 3, 3.25 and 3.5 mm and...